The case report describes a very rare cutaneous non-epitheliotropic B-cell lymphoma in an 11-year-old male Weimaraner dog, which presented with multiple cutaneous proliferations. In addition to numerous cytoplasmic fragments of lymphatic cells, the cytological examination of a fine-needle aspirate taken from a skin nodule revealed a population of pleomorphic plump to spindle-shaped cells with round to oval nuclei, fine chromatin structure, moderate amounts of a lightly basophilic cytoplasm and predominantly indistinct cell boundaries. These findings suggested a possible cutaneous spindle-cell lymphoma, thus a biopsy was taken. In the histopathological examination, the cells displayed no epitheliotropism and immunohistochemically they were positive for multiple B-cell markers. In addition to the rarity of cutaneous non-epitheliotropic B-cell lymphomas per se, the special feature of this case is the atypical spindle-cell morphology of the lymphatic cells. A spindle-cell variant of cutaneous B-cell lymphoma has to date only been described in human medicine.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.15654/TPK-170254 | DOI Listing |
Cureus
December 2024
Department of Histopathology and Cytology, Apollo Cancer Center, Chennai, IND.
Background and objective Lymphomas can involve the gastrointestinal (GI) tract as a primary disease or as a secondary spread of systemic disease. The GI tract is a key site for extranodal lymphomas, with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) occurring in this region. This study aimed to analyze the demography, anatomic distribution, histological subtypes, and immunomorphological characteristics of all lymphomas with a primary GI presentation at a quaternary care hospital in southern India.
View Article and Find Full Text PDFHeliyon
December 2024
Department of Hematology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, China.
Purpose: The tumor microenvironment (TME) in lymphoma is influenced by M2 macrophages. This research proposes an novel predictive model that leverages M2 macrophage-associated genes to categorize risk, forecast outcomes, and evaluate the immune profile in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) undergoing R-CHOP therapy.
Methods: Gene expression data and clinical information from DLBCL patients were retrieved from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases.
Am J Surg Pathol
January 2025
Department of Pathology, University Hospital Henri Mondor, AP-HP, Créteil, France.
Lymphomas of T-follicular helper origin (T-follicular helper-cell lymphoma [TFHL]) are often accompanied by an expansion of B-immunoblasts, occasionally with Hodgkin/Reed-Sternberg-like (HRS-like) cells, making the differential diagnosis with classic Hodgkin lymphoma (CHL) difficult. We compared the morphologic, immunophenotypic, and molecular features of 15 TFHL and 12 CHL samples and discussed 4 challenging cases of uncertain diagnosis. Compared with CHL, TFHL disclosed more frequent sparing of subcortical sinuses, high-endothelium venule proliferation, dendritic cell meshwork expansion, T-cell atypia, and aberrant T-cell immunophenotype.
View Article and Find Full Text PDFAm J Hematol
January 2025
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Despite advances in treatment, approximately 15% of patients with diffuse large B-cell lymphoma (DLBCL) who achieve complete remission (CR) after first-line therapy will experience a relapse. However, there is no consensus on the optimal follow-up strategies for detecting relapse after achieving CR. This population-based study, based on the Danish Lymphoma Registry (LYFO), identified a total of 1634 patients diagnosed with DLBCL between 2010 and 2017, including 105 patients who achieved CR following first-line R-CHOP-like therapy and subsequently relapsed.
View Article and Find Full Text PDFPediatr Blood Cancer
January 2025
Laboratorio de Genética de Neoplasias Linfoides, Instituto de Medicina Experimental, CONICET-Academia Nacional de Medicina, Buenos Aires, Argentina.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!